Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000053

Options or other derivatives

  • EVP, Chief Development Officer acquired 37,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-15 Grant or award : show line 1 in the form Performance Restricted Stock Units +17,000 $0.00 17,000 42,801 D
2024-01-15 Grant or award : show line 2 in the form Restricted Stock Unit +20,400 $0.00 20,400 66,477 D
Loading xslF345X05/edgardoc.xml…